Latest Regulatory Approvals News

Southern Palladium has raised A$8 million through a strategic placement to accelerate its Definitive Feasibility Study and staged mine development at the Bengwenyama PGM project, backed by a major cornerstone investor.

Cleo Diagnostics unveils a pioneering blood test for early ovarian cancer detection, boasting superior accuracy to existing methods and targeting a significant U.S. market opportunity.

Cochlear Limited has lowered its FY25 earnings guidance due to slower-than-expected sales growth and a sharper decline in Services revenue. Despite this, implant unit growth remains on track, driven by emerging markets.

Talga Group has cleared the last regulatory hurdle for its Nunasvaara South graphite mine in Sweden, paving the way for production of battery anode materials critical to the green transition.

EVE Health Group has launched a $1.5 million capital raise alongside the acquisition of biotech firm Nextract, aiming to expand its footprint in health and pharmaceutical products focused on erectile dysfunction and period pain.

Spartan Resources has dispatched the crucial transaction booklet to shareholders detailing Ramelius Resources’ proposed acquisition, with the Spartan Board unanimously recommending support for the deal.

St George Mining has initiated a 10,000-metre drilling program at its Araxá Project in Brazil, aiming to significantly grow its already substantial rare earths and niobium resource. The campaign combines multiple drilling techniques alongside a high-resolution airborne magnetic survey to unlock further mineral potential.

North Stawell Minerals Ltd (ASX, NSM) is advancing its gold exploration ambitions with a $3.6 million equity raising aimed at funding key projects near the prolific Stawell Gold Mine in Victoria. The capital injection will support drilling and geological modelling to unlock new gold discoveries under a thin sediment cover.

PYC Therapeutics has secured Safety Review Committee approval to increase dosing in its clinical trial for a novel treatment targeting Autosomal Dominant Optic Atrophy, a rare blinding genetic disease. This milestone marks a significant step forward in the development of PYC-001, a first-in-class RNA therapy.

Olympio Metals has secured approvals to drill up to 38 holes totaling 10,000 meters at its Bousquet Gold Project in Quebec, aiming to unlock high-grade gold potential along the prolific Cadillac Break. Drilling is set to start imminently, targeting promising zones with historic intercepts.

OD6 Metals has secured a second regulatory approval to extend its Phase 2 drilling at the historic Gulf Creek Copper Project, targeting promising repeat mineral structures and deepening exploration near recent high-grade intercepts.

Finder Energy has spotlighted its Kuda Tasi and Jahal oil development opportunity at the APAC Energy Capital Assembly, revealing a robust resource base and a streamlined development strategy promising rapid returns.